SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-136682
Filing Date
2024-05-13
Accepted
2024-05-13 07:01:07
Documents
19
Period of Report
2024-05-10
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d822752d8k.htm   iXBRL 8-K 33691
2 EX-4.1 d822752dex41.htm EX-4.1 73822
3 EX-4.2 d822752dex42.htm EX-4.2 73584
4 EX-5.1 d822752dex51.htm EX-5.1 9180
5 EX-99.1 d822752dex991.htm EX-99.1 126222
9 GRAPHIC g822752g0512201927637.jpg GRAPHIC 1477
10 GRAPHIC g822752g0512202429031.jpg GRAPHIC 2495
  Complete submission text file 0001193125-24-136682.txt   529473

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA itos-20240510.xsd EX-101.SCH 2881
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE itos-20240510_lab.xml EX-101.LAB 17979
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itos-20240510_pre.xml EX-101.PRE 11279
22 EXTRACTED XBRL INSTANCE DOCUMENT d822752d8k_htm.xml XML 3632
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39401 | Film No.: 24936832
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)